Prati
Carolin Zitzmann
Naslov
Citirano
Citirano
Godina
In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness
R Ke, C Zitzmann, DD Ho, RM Ribeiro, AS Perelson
Proceedings of the National Academy of Sciences 118 (49), e2111477118, 2021
1602021
Mathematical Analysis of Viral Replication Dynamics and Antiviral Treatment Strategies: From Basic Models to Age-Based Multi-Scale Modeling
C Zitzmann, L Kaderali
Frontiers in microbiology 9, 2018
882018
Convergent use of phosphatidic acid for hepatitis C virus and SARS-CoV-2 replication organelle formation
K Tabata, V Prasad, D Paul, JY Lee, MT Pham, WI Twu, CJ Neufeldt, ...
Nature communications 12 (1), 7276, 2021
612021
The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy
NF McMyn, J Varriale, EJ Fray, C Zitzmann, H MacLeod, J Lai, A Singhal, ...
The Journal of clinical investigation 133 (17), 2023
592023
Kinetics of SARS-CoV-2 infection in the human upper and lower respiratory tracts and their relationship with infectiousness
R Ke, C Zitzmann, RM Ribeiro, AS Perelson
MedRxiv, 2020.09. 25.20201772, 2020
552020
Automated characterization and parameter-free classification of cell tracks based on local migration behavior
Z Mokhtari, F Mech, C Zitzmann, M Hasenberg, M Gunzer, MT Figge
PLoS One 8 (12), e80808, 2013
392013
A coupled mathematical model of the intracellular replication of dengue virus and the host cell immune response to infection
C Zitzmann, B Schmid, A Ruggieri, AS Perelson, M Binder, ...
Frontiers in microbiology 11, 725, 2020
322020
Antiretroviral therapy reveals triphasic decay of intact SIV genomes and persistence of ancestral variants
EJ Fray, F Wu, FR Simonetti, C Zitzmann, N Sambaturu, C Molina-Paris, ...
Cell host & microbe 31 (3), 356-372. e5, 2023
182023
Mathematical modeling of hepatitis C RNA replication, exosome secretion and virus release
C Zitzmann, L Kaderali, AS Perelson
PLOS Computational Biology 16 (11), e1008421, 2020
122020
Modeling the emergence of viral resistance for SARS-CoV-2 during treatment with an anti-spike monoclonal antibody
T Phan, C Zitzmann, KW Chew, DM Smith, ES Daar, DA Wohl, JJ Eron, ...
PLoS Pathogens 20 (4), e1011680, 2024
72024
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies
C Zitzmann, C Dächert, B Schmid, H Van der Schaar, M van Hemert, ...
PLoS computational biology 19 (4), e1010423, 2023
62023
How robust are estimates of key parameters in standard viral dynamic models?
C Zitzmann, R Ke, RM Ribeiro, AS Perelson
PLOS Computational Biology 20 (4), e1011437, 2024
52024
The kinetics of SARS-CoV-2 infection based on a human challenge study
SA Iyaniwura, RM Ribeiro, C Zitzmann, T Phan, R Ke, AS Perelson
Proceedings of the National Academy of Sciences 121 (46), e2406303121, 2024
32024
Biphasic decay of intact SHIV genomes following initiation of antiretroviral therapy complicates analysis of interventions targeting the reservoir
MR Kumar, EJ Fray, AM Bender, C Zitzmann, RM Ribeiro, AS Perelson, ...
Proceedings of the National Academy of Sciences 120 (43), e2313209120, 2023
32023
How reliable are estimates of key parameters in viral dynamic models?
C Zitzmann, R Ke, RM Ribeiro, AS Perelson
bioRxiv, 2023.08. 17.553792, 2023
12023
MULTISCALE MODELING OF LEAD-IN RESULTS FROM A PHASE 2 STUDY OF AN 8-WEEK COMBINATION REGIMEN OF BEMNIFOSBUVIR AND RUZASVIR IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
C Zitzmann, R Ribeiro, S Izmailyan, K Pietropaolo, A Horga, XJ Zhou, ...
HEPATOLOGY 80, S378-S379, 2024
2024
Consistent social information perceived in animated backgrounds improves ensemble perception of facial expressions
M Zhao, J Wang
Perception 53 (8), 563-578, 2024
2024
Last in first out: SIV proviruses seeded later in infection are harbored in short-lived CD4+ T cells
N Sambaturu, EJ Fray, F Wu, C Zitzmann, FR Simonetti, DH Barouch, ...
bioRxiv, 2023
2023
Mathematical Modeling of Plus‐Strand RNA Virus Replication
C Zitzmann
2023
Modeling Viral Resistance to Monotherapy with Monoclonal Antibody Treatment for SARS-CoV-2
T Phan, C Zitzmann, AS Perelson, RM Ribeiro, R Ke
2022
Sustav trenutno ne može provesti ovu radnju. Pokušajte ponovo kasnije.
Članci 1–20